Osteoarthritis Trial, Recruiting NCT06512727 Sponsor: University of Florida Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06512727
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as part of the Black American diaspora, including Black/African American or Afro-Caribbean communities
  • People between the ages of 50 and 92 years old
  • People who have had ongoing or recurring pain in their bones, joints, muscles, or related soft tissues for 6 months or longer
  • People who have a long-term musculoskeletal condition (such as osteoarthritis or chronic lower back pain) affecting at least one area of the lower body, such as the hip, knee, lower back, or ankle
  • People who experience aching, stiffness, or swelling in a major lower body joint or the lower back on most days of the week (4–5 days out of 7)
  • People who have health insurance in the state of Florida, or who a Florida health insurance plan determines to be eligible for coverage (such as Medicare, Medicaid, Medicare Advantage, Blue Cross/Blue Shield, Humana, Aetna, or similar)
  • People who are able to read, write, and understand English at around a sixth-grade level

Who may not be able to join:

  • People who are not willing to be randomly assigned to either of the two study groups
  • People who have been diagnosed with sickle cell disease or a related thalassemia condition
  • People who have had a major neurological event such as a stroke, or who currently have a neurological disease such as Parkinson's disease, multiple sclerosis, or epilepsy
  • People who have had a serious heart or circulation problem in the past 6 months — such as a heart attack, heart bypass surgery, valve replacement, blood clot in the lungs, or a blood clot in a vein — or people with blood pressure that is too high or too low (confirm with trial site for exact measurements)
  • People who are currently receiving chemotherapy or radiation therapy to treat active cancer
  • People with severe physical limitations, such as needing a wheelchair as their main way of getting around, or being unable to dress, bathe, use the toilet, or move between positions without help
  • People who have been hospitalised for a serious mental health condition within the past 12 months
  • People with severe hearing loss or blindness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Staja Q Booker, PhD, RN, University of Florida

Phone: 352-273-6351

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 May 2025
Est. completion
1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in movement-evoked pain from baseline to 4 weeks (post-intervention)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov